Remove Biomarkers Remove Blood Pressure Remove Stroke
article thumbnail

Abstract WP266: Prediction of Stroke Incidence Using Machine Learning: The Suita Study

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page AWP266-AWP266, February 1, 2024. Background:This population-based study investigated the potential of machine learning algorithms to predict stroke incidence and identify important risk factors. These clusters were categorized into high-, medium-, and low-risk groups.

Stroke 40
article thumbnail

Abstract 020: Undulating Flow Velocities as an Induced Test of Autoregulation After Thrombectomy for Acute Ischemic Stroke

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionLoss of autoregulation after endovascular therapy (EVT) for large‐artery acute ischemic stroke (AIS) is well documented. [1] Further studies are required to clarify the utility of this biomarker in guiding post‐EVT care.

Stroke 40
article thumbnail

Abstract 133: Associations of Genetically Predicted Iron Status and Ischemic Stroke Subtypes: A Mendelian Randomization Study

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page A133-A133, February 1, 2024. Mendelian randomization (MR) studies suggest a causal effect of Fe status on ischemic stroke (IS).

BMI 40
article thumbnail

Metabolomic profiling reveals key metabolites associated with hypertension progression

Frontiers in Cardiovascular Medicine

It is characterized by asymptomatic elevations in blood pressure beyond normal levels but not yet reaching the threshold for hypertension. If left uncontrolled, pre-hypertension can progress to hypertension, thereby increasing the risk of serious complications such as heart disease, stroke, kidney damage, and others.

article thumbnail

Characteristics of circulatory failure after out-of-hospital cardiac arrest: a prospective cohort study

Open Heart

We measured the development in cardiac power output (CPO), stroke work (SW), aortic elastance, microcirculatory metabolism, inflammatory and cardiac biomarkers and need for vasoactive medications. to 0.96), while inflammatory biomarkers and other cardiac biomarkers did not predict the duration of vasoactive pressure support.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 21 Luckily, each of these risks can be measured by simple blood tests. 4 In the U.S. 22 In general, hsCRP values above 2.0

article thumbnail

Abstract TP29: Neurodegenerative Plasma Biomarker Associations With Cognitive Resilience in Adults With High White Matter Hyperintensity Volume: A Post-Hoc Analysis of Systolic Blood Pressure Intervention Trial Memory & Cognition in Decreased Hypertension (SPRINT MIND)

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page ATP29-ATP29, February 1, 2024. Neurodegenerative plasma biomarkers may be associated with cognitive decline via vascular processes causing higher WMHv such as cerebral amyloid angiopathy & inflammatory small vessel disease. were female & 66% were Non-Hispanic white.